BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32979630)

  • 1. Generation of the human induced pluripotent stem cell line (SHAMUi001-A) carrying the heterozygous c.-128G>T mutation in the 5'-UTR of the ANKRD26 gene.
    Tan C; Dai L; Yang W; Li F; Wang L; Xiao Y; Wang X; Zhang Y; Wang Y; Zeng C; Xiang Z; Zhang X; Zhang W; Ran Q; Chen M; Li Z; Chen L
    Stem Cell Res; 2020 Oct; 48():102002. PubMed ID: 32979630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.
    Bluteau D; Balduini A; Balayn N; Currao M; Nurden P; Deswarte C; Leverger G; Noris P; Perrotta S; Solary E; Vainchenker W; Debili N; Favier R; Raslova H
    J Clin Invest; 2014 Feb; 124(2):580-91. PubMed ID: 24430186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia.
    Marconi C; Canobbio I; Bozzi V; Pippucci T; Simonetti G; Melazzini F; Angori S; Martinelli G; Saglio G; Torti M; Pastan I; Seri M; Pecci A
    J Hematol Oncol; 2017 Jan; 10(1):18. PubMed ID: 28100250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rare Big Chinese Family With Thrombocytopenia 2: A Case Report and Literature Review.
    Tan C; Dai L; Chen Z; Yang W; Wang Y; Zeng C; Xiang Z; Wang X; Zhang X; Ran Q; Guo H; Li Z; Chen L
    Front Genet; 2020; 11():340. PubMed ID: 32351539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between mutations in the 5' UTR of ANKRD26 gene and inherited thrombocytopenia with predisposition to myeloid malignancies. An Egyptian study.
    Zidan NI; AbdElmonem DM; Elsheikh HM; Metwally EA; Mokhtar WA; Osman GM
    Platelets; 2021 Jul; 32(5):642-650. PubMed ID: 32659145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2.
    Pippucci T; Savoia A; Perrotta S; Pujol-Moix N; Noris P; Castegnaro G; Pecci A; Gnan C; Punzo F; Marconi C; Gherardi S; Loffredo G; De Rocco D; Scianguetta S; Barozzi S; Magini P; Bozzi V; Dezzani L; Di Stazio M; Ferraro M; Perini G; Seri M; Balduini CL
    Am J Hum Genet; 2011 Jan; 88(1):115-20. PubMed ID: 21211618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases.
    Zaninetti C; Santini V; Tiniakou M; Barozzi S; Savoia A; Pecci A
    J Thromb Haemost; 2017 Dec; 15(12):2388-2392. PubMed ID: 28976612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited Thrombocytopenia Caused by Germline
    Kewan T; Noss R; Godley LA; Rogers HJ; Carraway HE
    J Investig Med High Impact Case Rep; 2020; 8():2324709620938941. PubMed ID: 32618208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.
    Basso-Valentina F; Donada A; Manchev VT; Lisetto M; Balayn N; Martin JE; Muller D; Oyarzun CPM; Duparc H; Arkoun B; Cumin A; Faivre L; Droin N; Biunno I; Pecci A; Balduini A; Debili N; Antony-Debré I; Marty C; Vainchenker W; Plo I; Favier R; Raslova H
    Haematologica; 2023 Aug; 108(8):2130-2145. PubMed ID: 36794499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and natural history of variants in the
    Vyas H; Alcheikh A; Lowe G; Stevenson WS; Morgan NV; Rabbolini DJ
    Platelets; 2022 Nov; 33(8):1107-1112. PubMed ID: 35587581
    [No Abstract]   [Full Text] [Related]  

  • 11. Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutation.
    Meraviglia V; Ganesh S; Arendzen CH; Freund C; Sommariva E; Rossini A; Bellin M
    Stem Cell Res; 2021 Jul; 54():102426. PubMed ID: 34134068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of two induced pluripotent stem cell lines with heterozygous and homozygous GAG deletion in TOR1A gene from a healthy hiPSC line.
    Akter M; Cui H; Chen YH; Ding B
    Stem Cell Res; 2021 Oct; 56():102536. PubMed ID: 34536661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation.
    Meraviglia V; Arendzen CH; Tok M; Freund C; Maione AS; Sommariva E; Bellin M
    Stem Cell Res; 2020 Jul; 46():101835. PubMed ID: 32485643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.
    Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
    Stem Cell Res; 2019 May; 37():101437. PubMed ID: 31009818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript.
    Wahlster L; Verboon JM; Ludwig LS; Black SC; Luo W; Garg K; Voit RA; Collins RL; Garimella K; Costello M; Chao KR; Goodrich JK; DiTroia SP; O'Donnell-Luria A; Talkowski ME; Michelson AD; Cantor AB; Sankaran VG
    J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33857290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA binding protein 2 mediated ankyrin repeat domain containing 26 high expression in myeloid-derived cell lines.
    Jiang YZ; Hu LY; Chen MS; Wang XJ; Tan CN; Xue PP; Yu T; He XY; Xiang LX; Xiao YN; Li XL; Ran Q; Li ZJ; Chen L
    World J Stem Cells; 2024 May; 16(5):538-550. PubMed ID: 38817334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms.
    Sullivan MJ; Palmer EL; Botero JP
    Curr Hematol Malig Rep; 2022 Oct; 17(5):105-112. PubMed ID: 35751752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a human induced pluripotent stem cell line (SDQLCHi004-A) from a patient with nemaline myopathy-4 disease carrying heterozygous mutation in TPM2 gene.
    Ma Y; Zhang H; Yang X; Li Y; Guan J; Lv Y; Li H; Liu Y; Gai Z
    Stem Cell Res; 2019 Oct; 40():101559. PubMed ID: 31526942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene.
    Mura M; Pisano F; Stefanello M; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M
    Stem Cell Res; 2019 Apr; 36():101416. PubMed ID: 30878014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a human induced pluripotent stem cell line (MUi010-A) from skin fibroblast of patient carrying a c.2104C>T mutation in MYH9 gene.
    Tangprasittipap A; Jittorntrum B; Kadegasem P; Sasanakul W; Sirachainan N; Kitiyanant N; Hongeng S
    Stem Cell Res; 2019 Apr; 36():101397. PubMed ID: 30798146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.